EMA
- Application: EMEA/H/C/005406
- Local brand name: Okedi
- Status: approved
Risperdal (risperidone) regulatory status in European Union.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA has authorised it.
Johnson & Johnson (Janssen) is the originator. The local marketing authorisation holder may differ — check the official source linked above.